Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Treasury Shares (2019 - 2025)

Dr Reddys Laboratories (RDY) has 6 years of Treasury Shares data on record, last reported at $11.9 million in Q1 2024.

  • For Q1 2024, Treasury Shares fell 22.7% year-over-year to $11.9 million; the TTM value through Mar 2024 reached $11.9 million, down 22.7%, while the annual FY2024 figure was $12.0 million, 24.31% down from the prior year.
  • Treasury Shares reached $11.9 million in Q1 2024 per RDY's latest filing, down from $15.4 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $27.0 million in Q1 2021 and bottomed at $11.9 million in Q1 2024.
  • Average Treasury Shares over 5 years is $17.9 million, with a median of $15.4 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: surged 94.27% in 2021, then fell 27.5% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $13.9 million in 2020, then soared by 94.27% to $27.0 million in 2021, then fell by 21.07% to $21.3 million in 2022, then dropped by 27.5% to $15.4 million in 2023, then fell by 22.7% to $11.9 million in 2024.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $11.9 million in Q1 2024, $15.4 million in Q1 2023, and $21.3 million in Q1 2022.